Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

An overview of recent health-related developments includes RFK Jr.'s controversial nomination as health secretary, PEPFAR's ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

Recent health news covers significant events like Pfizer's diversity program settlement, AstraZeneca's halted UK investment, ...

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.

Quality, high-yield dividend stocks can deliver dependable passive income to help retirees offset inflation. These five make sense now.

Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to boost the pipeline of Black, Latino and Native American people in ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...